Sesen Bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $158.19 million.
The company employs approximately 27 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Sesen Bio Inc. reported $80.00 million in revenue, generating net income of $-34.88 Thousand.
Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker SESN.